Gastroenterology Elsewhere

Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn’s disease

Volume 27 · Issue 6 Publish Date: November 15, 2016
Full Text PDF
DOI
Ryan D. Heath
Division of Gastroenterology and Hepatology, University of Missouri-Columbia 1 Hospital Drive, Columbia, MO, USA
Veysel Tahan
Division of Gastroenterology and Hepatology, University of Missouri-Columbia 1 Hospital Drive, Columbia, Missouri, USA
Heath, R. D., & Tahan, V. (2016). Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn’s disease. Turkish Journal of Gastroenterology, 27(6), 568–569. https://doi.org/10.5152/tjg.2016.160008
Full Text Full Text PDF

Abstract

Crohn’s disease is a common inflammatory bowel disor der with potentially debilitating complications.

Most read articles by the same author(s)

1 2 > >> 
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 27 · Issue 6
Pages 568-569
History
Published Online November 15, 2016
Copyright
Affiliations
Ryan D. Heath
Division of Gastroenterology and Hepatology, University of Missouri-Columbia 1 Hospital Drive, Columbia, MO, USA
Veysel Tahan
Division of Gastroenterology and Hepatology, University of Missouri-Columbia 1 Hospital Drive, Columbia, Missouri, USA
Cite this Article
Heath, R. D., & Tahan, V. (2016). Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn’s disease. Turkish Journal of Gastroenterology, 27(6), 568–569. https://doi.org/10.5152/tjg.2016.160008
Outlines